Open access · CC-BY
via OpenAlex
Epigenetic crossroads in metabolic and cardiovascular health: the role of DNA methylation in type 2 diabetes and cardiovascular diseases
Suneesh Kaimala, Lidya K. Yassin, Mohammad I. K. Hamad, Mohammed Zohair Allouh, Prabha Sampath, Juma Alkaabi, Melvin Khee‐Shing Leow, Safa A. S. Shehab, Suraiya Anjum Ansari, Bright Starling Emerald
Cardiovascular Diabetology · 2025 · ▲ 14 citations
Abstract
Type 2 diabetes (T2D) and cardiovascular diseases (CVD), part of the metabolic syndrome (MetS), are major contributors to the global health crisis today. A recent report from the World Health Organisation estimates that 17.9 million lives are lost each year to CVD, and one-third of these are premature. The international diabetes federation estimates that around 537 million adults aged between 20 and 79 years are living with diabetes. People with diabetes are suggested to have twice the risk of developing CVD. Epigenetic modifications are being increasingly recognised as the key mediators linking genetic and environmental conditions to metabolic dysfunction. Among these, DNA methylation plays a crucial role in modulating gene expression and influencing pathways involved in glucose homeostasis, inflammation, and vascular integrity. Despite the advances in our understanding of the role of epigenetic alterations in metabolic diseases, including that of T2D, the mechanisms driving selective methylation changes and their long-term impact on cardiovascular health are still not well understood. This review synthesises the current knowledge on DNA methylation dynamics in T2D and their role towards the progression of CVD and explores their potential as biomarkers and therapeutic targets. Understanding the interplay between metabolism and epigenetics in the pathogenesis of T2D and CVD could provide critical insights for early disease identification and the development of novel epigenome-targeted therapeutic strategies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s12933-025-02800-x
- Canonical
- link ↗
- Fetched
- 2026-11-05 MST
Cite this
APA
Kaimala, S., Yassin, L.K., Hamad, M.I.K., Allouh, M.Z., Sampath, P., Alkaabi, J., Leow, M.K., Shehab, S.A.S., Ansari, S.A., & Emerald, B.S. (2025). Epigenetic crossroads in metabolic and cardiovascular health: the role of DNA methylation in type 2 diabetes and cardiovascular diseases. <em>Cardiovascular Diabetology</em>. https://doi.org/10.1186/s12933-025-02800-x
Vancouver
Kaimala S, Yassin LK, Hamad MIK, Allouh MZ, Sampath P, Alkaabi J, et al. Epigenetic crossroads in metabolic and cardiovascular health: the role of DNA methylation in type 2 diabetes and cardiovascular diseases. Cardiovascular Diabetology. 2025. doi:10.1186/s12933-025-02800-x.
BibTeX
@article{suneesh2025Epigen,
title = {Epigenetic crossroads in metabolic and cardiovascular health: the role of DNA methylation in type 2 diabetes and cardiovascular diseases},
author = {Suneesh Kaimala and Lidya K. Yassin and Mohammad I. K. Hamad and Mohammed Zohair Allouh and Prabha Sampath and Juma Alkaabi and Melvin Khee‐Shing Leow and Safa A. S. Shehab and Suraiya Anjum Ansari and Bright Starling Emerald},
journal = {Cardiovascular Diabetology},
year = {2025},
doi = {10.1186/s12933-025-02800-x},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Lung 2026
Open access · OA
Impact of Epigenetic Modifications in Airway Diseases. Role of Inflammation, Environmental Factors and Aging.
Antioxidants and Redox Signaling 2017
Open access · OA
Epigenetics and Immunometabolism in Diabetes and Aging
Frontiers in Cell and Developmental Biology 2022
Open access · CC-BY
The epigenetic aging, obesity, and lifestyle
Frontiers in Pharmacology 2022
Open access · CC-BY
DNA Methylation Aberrant in Atherosclerosis
Diabetologia 2026
Open access · OA
Comparative physiology and biomimetics in metabolic and environmental health: what can we learn from extreme animal phenotypes?
Deposito Adademico Digital Universidad De Navarra (University of Navarra) 2019
Preprint